ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is PTC Therapeutics, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 32.94% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
2
With a fall in PBT of -175.08%, the company declared Very Negative results in Dec 25
- The company has declared negative results in Jan 70 after 2 consecutive negative quarters
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.4 times
- NET SALES(Q) Lowest at USD 164.68 MM
- INTEREST(Q) Highest at USD 55.19 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 20.26%, its profits have risen by 413% ; the PEG ratio of the company is 0
4
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -0.96% over the previous quarter and currently hold 0.81% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is PTC Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
PTC Therapeutics, Inc.
20.26%
1.54
49.26%
S&P 500
11.87%
0.62
19.30%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
35.37%
EBIT Growth (5y)
32.94%
EBIT to Interest (avg)
-2.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
9.29
Sales to Capital Employed (avg)
4.72
Tax Ratio
8.68%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
-26.89
EV to EBIT
4.53
EV to EBITDA
4.33
EV to Capital Employed
-2.10
EV to Sales
2.24
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 711.2 MM
RAW MATERIAL COST(Y)
Fallen by 0.79% (YoY
CASH AND EQV(HY)
Highest at USD 3,633.19 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 10.18 times
-30What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.4 times
NET SALES(Q)
Lowest at USD 164.68 MM
INTEREST(Q)
Highest at USD 55.19 MM
OPERATING PROFIT(Q)
Lowest at USD -68.72 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -41.73 %
PRE-TAX PROFIT(Q)
Lowest at USD -149.36 MM
NET PROFIT(Q)
Lowest at USD -145.24 MM
EPS(Q)
Lowest at USD -1.67
Here's what is working for PTC Therapeutics, Inc.
Operating Cash Flow
Highest at USD 711.2 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Cash and Eqv
Highest at USD 3,633.19 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio
Highest at 10.18 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by 0.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 12.9 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for PTC Therapeutics, Inc.
Net Sales
At USD 164.68 MM has Fallen at -62.98%
over average net sales of the previous four periods of USD 444.79 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -149.36 MM has Fallen at -167.33%
over average net sales of the previous four periods of USD 221.84 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -145.24 MM has Fallen at -164.68%
over average net sales of the previous four periods of USD 224.53 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 55.19 MM has Grown at 69.33%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Inventory Turnover Ratio
Lowest at 1.4 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Net Sales
Lowest at USD 164.68 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Interest
Highest at USD 55.19 MM
in the last five periods and Increased by 69.33% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Profit
Lowest at USD -68.72 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at -41.73 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD -149.36 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -145.24 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -1.67
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
